Teladoc Health [TDOC] vs Schrodinger [SDGR] Detailed Stock Comparison
Teladoc Health
NYSE
Loading...
Schrodinger
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Teladoc Health wins in 13 metrics, Schrodinger wins in 5 metrics, with 0 ties. Teladoc Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Teladoc Health | Schrodinger | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.50 | 44.39 | Teladoc Health |
| Price-to-Book Ratio | 1.12 | 4.42 | Teladoc Health |
| Debt-to-Equity Ratio | 72.78 | 33.38 | Schrodinger |
| PEG Ratio | 0.02 | -2.19 | Schrodinger |
| EV/EBITDA | 103.14 | -6.33 | Schrodinger |
| Profit Margin (TTM) | -8.16% | -76.22% | Teladoc Health |
| Operating Margin (TTM) | -7.29% | -96.61% | Teladoc Health |
| Return on Equity | -14.18% | -44.40% | Teladoc Health |
| Return on Assets (TTM) | -3.57% | -17.52% | Teladoc Health |
| Free Cash Flow (TTM) | $169.63M | $-164.68M | Teladoc Health |
| 1-Year Return | -6.85% | 20.49% | Schrodinger |
| Price-to-Sales Ratio (TTM) | 0.63 | 6.37 | Teladoc Health |
| Enterprise Value | $1.95B | $1.18B | Teladoc Health |
| EV/Revenue Ratio | 0.77 | 4.96 | Teladoc Health |
| Gross Profit Margin (TTM) | 69.85% | 47.77% | Teladoc Health |
| Revenue per Share (TTM) | $15 | $3 | Teladoc Health |
| Earnings per Share (Diluted) | $-1.15 | $-2.48 | Teladoc Health |
| Beta (Stock Volatility) | 1.91 | 1.74 | Schrodinger |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Teladoc Health vs Schrodinger Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Teladoc Health | -4.88% | 4.51% | 9.31% | 6.20% | 18.53% | -9.98% |
| Schrodinger | 3.40% | 6.24% | 9.52% | 3.20% | 16.91% | 4.36% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Teladoc Health | -6.85% | -63.00% | -96.13% | -52.39% | -69.39% | -69.39% |
| Schrodinger | 20.49% | -2.83% | -63.26% | -33.30% | -33.30% | -33.30% |
News Based Sentiment: Teladoc Health vs Schrodinger
Teladoc Health
News based Sentiment: MIXED
October was a month of conflicting signals for Teladoc, with continued financial challenges offset by a surprising stock surge and strategic initiatives. The regulatory environment remains a key risk, creating a mixed outlook for investors. The combination of positive market reaction and underlying financial concerns makes this a significant month for the company.
Schrodinger
News based Sentiment: MIXED
Schrodinger experienced a blend of positive and negative developments in October. While the Q2 earnings beat and analyst upgrade were encouraging, the stock's volatility, mixed analyst ratings, and continued unprofitability create a complex investment picture. The company's future success depends heavily on its drug pipeline and software business growth.
Performance & Financial Health Analysis: Teladoc Health vs Schrodinger
| Metric | TDOC | SDGR |
|---|---|---|
| Market Information | ||
| Market Cap | $1.59B | $1.52B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 8,888,160 | 1,092,130 |
| 90 Day Avg. Volume | 5,961,557 | 1,035,247 |
| Last Close | $8.57 | $21.29 |
| 52 Week Range | $6.35 - $15.21 | $16.60 - $28.47 |
| % from 52W High | -43.66% | -25.22% |
| All-Time High | $308.00 (Feb 15, 2021) | $117.00 (Feb 22, 2021) |
| % from All-Time High | -97.22% | -81.80% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.16% |
| Quarterly Earnings Growth | -0.02% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | -0.08% | -0.76% |
| Operating Margin (TTM) | -0.07% | -0.97% |
| Return on Equity (TTM) | -0.14% | -0.44% |
| Debt to Equity (MRQ) | 72.78 | 33.38 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.05 | $4.66 |
| Cash per Share (MRQ) | $3.85 | $6.12 |
| Operating Cash Flow (TTM) | $303.43M | $27.50M |
| Levered Free Cash Flow (TTM) | $209.72M | $-6,255,750 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Teladoc Health vs Schrodinger
| Metric | TDOC | SDGR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.50 | 44.39 |
| Forward P/E | -10.12 | -8.34 |
| PEG Ratio | 0.02 | -2.19 |
| Price to Sales (TTM) | 0.63 | 6.37 |
| Price to Book (MRQ) | 1.12 | 4.42 |
| Market Capitalization | ||
| Market Capitalization | $1.59B | $1.52B |
| Enterprise Value | $1.95B | $1.18B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.77 | 4.96 |
| Enterprise to EBITDA | 103.14 | -6.33 |
| Risk & Other Metrics | ||
| Beta | 1.91 | 1.74 |
| Book Value per Share (MRQ) | $8.05 | $4.66 |
Financial Statements Comparison: Teladoc Health vs Schrodinger
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TDOC | SDGR |
|---|---|---|
| Revenue/Sales | $629.37M | $59.55M |
| Cost of Goods Sold | $196.83M | $28.43M |
| Gross Profit | $432.54M | $31.12M |
| Research & Development | $69.96M | $45.84M |
| Operating Income (EBIT) | $-54.94M | $-50.89M |
| EBITDA | $50.34M | $-36.21M |
| Pre-Tax Income | $-111.27M | $-59.78M |
| Income Tax | $-18.26M | $28,000 |
| Net Income (Profit) | $-93.01M | $-59.81M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TDOC | SDGR |
|---|---|---|
| Cash & Equivalents | $679.62M | $326.00M |
| Total Current Assets | $1.07B | $570.94M |
| Total Current Liabilities | $401.77M | $165.47M |
| Long-Term Debt | $1.03B | $99.41M |
| Total Shareholders Equity | $1.42B | $373.50M |
| Retained Earnings | $-16.36B | $-585.35M |
| Property, Plant & Equipment | $27.67M | $132.60M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TDOC | SDGR |
|---|---|---|
| Operating Cash Flow | $89.56M | $153.46M |
| Capital Expenditures | N/A | $-596,000 |
| Free Cash Flow | $31.63M | $143.47M |
| Debt Repayment | N/A | $-14,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TDOC | SDGR |
|---|---|---|
| Shares Short | 23.82M | 10.52M |
| Short Ratio | 5.40 | 10.53 |
| Short % of Float | 0.15% | 0.26% |
| Average Daily Volume (10 Day) | 8,888,160 | 1,092,130 |
| Average Daily Volume (90 Day) | 5,961,557 | 1,035,247 |
| Shares Outstanding | 173.41M | 72.87M |
| Float Shares | 174.74M | 57.82M |
| % Held by Insiders | 0.01% | 0.03% |
| % Held by Institutions | 0.74% | 1.08% |
Dividend Analysis & Yield Comparison: Teladoc Health vs Schrodinger
| Metric | TDOC | SDGR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |